Grand Jean Capital Management Has Trimmed Its Holding in Thermo Fisher Scientific (TMO) by $342,999 as Shares Rose; Oracle (ORCL) Stake Maintained by F&V Capital Management Llc

September 14, 2018 - By Joshua Cleveland

Oracle Corporation (NYSE:ORCL) Logo

Grand Jean Capital Management Inc decreased its stake in Thermo Fisher Scientific (TMO) by 1.78% based on its latest 2018Q2 regulatory filing with the SEC. Grand Jean Capital Management Inc sold 1,657 shares as the company’s stock rose 10.49% with the market. The institutional investor held 91,328 shares of the industrial machinery and components company at the end of 2018Q2, valued at $18.92 million, down from 92,985 at the end of the previous reported quarter. Grand Jean Capital Management Inc who had been investing in Thermo Fisher Scientific for a number of months, seems to be less bullish one the $97.42B market cap company. The stock decreased 0.80% or $1.96 during the last trading session, reaching $241.87. About 334,936 shares traded. Thermo Fisher Scientific Inc. (NYSE:TMO) has risen 23.20% since September 14, 2017 and is uptrending. It has outperformed by 7.58% the S&P500. Some Historical TMO News: 25/04/2018 – THERMO FISHER SCIENTIFIC INC TMO.N FY2018 SHR VIEW $10.84, REV VIEW $23.60 BLN — THOMSON REUTERS l/B/E/S; 30/04/2018 – Mudrick Capital: Opposes Globalstar Inc.’s Proposed Merger Deal With Thermo Acquisitions Subsidiary; 25/04/2018 – Thermo Fisher raises 2018 forecast; 1st quarter profit beats; 25/04/2018 – THERMO FISHER SCIENTIFIC INC – CO IS RAISING 2018 REVENUE GUIDANCE TO A NEW RANGE OF $23.62 BLN TO $23.86 BLN; 28/03/2018 – BIOCEPT, THERMO FISHER SCIENTIFIC ANNOUNCE PACT; 16/03/2018 – Thermo Fisher Scientific Announces Plans to Build State-of-the-Art Pharma Services Facility in Rheinfelden (Baden) Germany; 12/04/2018 – Thermo Fisher Scientific to Showcase Clinical Research Advances in Immuno-Oncology at AACR; 15/03/2018 – Charit√© — Universit√§tsmedizin Berlin Joins Thermo Fisher Scientific’s Next-Generation Sequencing Center of Excellence Program; 25/04/2018 – Thermo Fisher Sees FY Rev $23.62B-$23.86B; 29/05/2018 – VIKRAM THERMO (INDIA) LTD VKMT.BO SAYS CO RECOMMENDED DIVIDEND AT 5 PCT

F&V Capital Management Llc increased its stake in Oracle Corp (ORCL) by 16.22% based on its latest 2018Q2 regulatory filing with the SEC. F&V Capital Management Llc bought 14,760 shares as the company’s stock rose 2.22% with the market. The institutional investor held 105,750 shares of the prepackaged software company at the end of 2018Q2, valued at $4.66M, up from 90,990 at the end of the previous reported quarter. F&V Capital Management Llc who had been investing in Oracle Corp for a number of months, seems to be bullish on the $195.34 billion market cap company. The stock increased 0.21% or $0.105 during the last trading session, reaching $49.065. About 9.91 million shares traded. Oracle Corporation (NYSE:ORCL) has declined 6.50% since September 14, 2017 and is downtrending. It has underperformed by 22.12% the S&P500. Some Historical ORCL News: 03/04/2018 – ORCL: Trump to dine with Oracle co-CEO Catz Tuesday, Bloomberg r; 11/04/2018 – Amobee Launches Sales Accelerator Solution, Powered by Oracle Data Cloud, Helping CPG Marketers Measure Offline Sales Impact of; 12/04/2018 – Oracle’s Moat Unveils New lnvalid Traffic Detection Capabilities, Achieves Rigorous MRC Accreditation for SIVT of Desktop and Mobile Web Traffic; 14/05/2018 – Influential And Oracle’s Moat Collaborate To Measure Viewability For Social Media Influencer Campaigns; 19/03/2018 – Oracle’s mixed earnings brightened by the cloud; 09/04/2018 – Fanatics Turns Customers into Even Bigger Fans with Oracle CX Cloud Suite; 15/05/2018 – Australia probes claim Google harvests data, consumers pay; 10/04/2018 – Oracle Al Powers Future of Customer Experience Management; 11/04/2018 – ORACLE CORP ORCL.N : MONNESS CRESPI HARDT STARTS COVERAGE WITH NEUTRAL RATING; 19/03/2018 – ORACLE: THE BULK OF BOOKINGS NOT FROM TRADITIONAL USER BASE

F&V Capital Management Llc, which manages about $158.07M and $174.31 million US Long portfolio, decreased its stake in Chevron Corp New (NYSE:CVX) by 3,225 shares to 54,532 shares, valued at $6.89 million in 2018Q2, according to the filing. It also reduced its holding in Cisco Sys Inc (NASDAQ:CSCO) by 8,515 shares in the quarter, leaving it with 188,875 shares, and cut its stake in Transocean Ltd (NYSE:RIG).

Investors sentiment decreased to 0.82 in Q2 2018. Its down 0.05, from 0.87 in 2018Q1. It is negative, as 73 investors sold ORCL shares while 564 reduced holdings. 107 funds opened positions while 414 raised stakes. 2.13 billion shares or 5.10% less from 2.24 billion shares in 2018Q1 were reported. Wunderlich Managemnt owns 0.87% invested in Oracle Corporation (NYSE:ORCL) for 28,569 shares. Csat Advisory Lp has 2.43% invested in Oracle Corporation (NYSE:ORCL) for 103,474 shares. Chesley Taft & Assocs Lc invested 0.8% of its portfolio in Oracle Corporation (NYSE:ORCL). Brandywine Global Invest Mngmt Limited Liability Co holds 1.02% in Oracle Corporation (NYSE:ORCL) or 3.64M shares. Smithbridge Asset Mngmt De invested in 2.19% or 77,782 shares. Fiduciary Mgmt Wi holds 7.39 million shares or 2.08% of its portfolio. Northstar Grp Incorporated has invested 0.24% of its portfolio in Oracle Corporation (NYSE:ORCL). Moreover, Cohen Mgmt Inc has 1.27% invested in Oracle Corporation (NYSE:ORCL). Evanson Asset Mgmt Limited Com has invested 0.07% in Oracle Corporation (NYSE:ORCL). At Bancorporation owns 19,910 shares. Richard Bernstein Advsrs Limited Liability Company reported 0.36% stake. Barton Mgmt invested 0.08% of its portfolio in Oracle Corporation (NYSE:ORCL). Cap Va holds 0.06% or 5,300 shares in its portfolio. Ftb Incorporated reported 26,300 shares stake. Essex Services stated it has 10,424 shares or 0.11% of all its holdings.

More notable recent Oracle Corporation (NYSE:ORCL) news were published by: Benzinga.com which released: “ORCL: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Oracle Corporation; Important …” on September 14, 2018, also Seekingalpha.com with their article: “Oracle Earnings Preview: Recent History Suggests A Move Down After The Report” published on September 10, 2018, Globenewswire.com published: “CLASS ACTION UPDATE for ORCL and HMNY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of …” on September 14, 2018. More interesting news about Oracle Corporation (NYSE:ORCL) were released by: Benzinga.com and their article: “Mike Khouw Sees Unusual Options Activity In Oracle” published on September 05, 2018 as well as Globenewswire.com‘s news article titled: “SHAREHOLDER ALERT: TSLA LCI CBS ORCL LOGM NLSN ZN RMTI HMNY SKX: The Law Offices of Vincent Wong …” with publication date: September 13, 2018.

Among 45 analysts covering Oracle (NYSE:ORCL), 24 have Buy rating, 0 Sell and 21 Hold. Therefore 53% are positive. Oracle had 129 analyst reports since July 30, 2015 according to SRatingsIntel. Oppenheimer maintained the stock with “Hold” rating in Thursday, June 22 report. The stock of Oracle Corporation (NYSE:ORCL) has “Buy” rating given on Friday, April 28 by Benchmark. The rating was maintained by RBC Capital Markets with “Hold” on Thursday, March 15. The rating was maintained by Morgan Stanley on Thursday, September 17 with “Overweight”. BMO Capital Markets initiated Oracle Corporation (NYSE:ORCL) rating on Friday, January 8. BMO Capital Markets has “Market Perform” rating and $42.0 target. As per Wednesday, June 20, the company rating was maintained by Bernstein. The stock has “Market Perform” rating by JMP Securities on Thursday, March 16. On Thursday, June 22 the stock rating was maintained by UBS with “Buy”. The firm has “Buy” rating by Stifel Nicolaus given on Thursday, June 22. As per Thursday, February 15, the company rating was maintained by Piper Jaffray.

Investors sentiment increased to 1.08 in 2018 Q2. Its up 0.22, from 0.86 in 2018Q1. It increased, as 43 investors sold TMO shares while 378 reduced holdings. 100 funds opened positions while 356 raised stakes. 332.19 million shares or 0.06% more from 331.98 million shares in 2018Q1 were reported. Wellington Shields Limited Liability Corp has 0.46% invested in Thermo Fisher Scientific Inc. (NYSE:TMO) for 13,410 shares. Evanson Asset Mgmt Ltd reported 0.06% of its portfolio in Thermo Fisher Scientific Inc. (NYSE:TMO). Farmers And Merchants Investments Incorporated has 0.01% invested in Thermo Fisher Scientific Inc. (NYSE:TMO). Bradley Foster & Sargent Ct invested in 200,120 shares or 1.48% of the stock. New York-based Oppenheimer Asset Management Incorporated has invested 0.23% in Thermo Fisher Scientific Inc. (NYSE:TMO). Griffin Asset Mngmt reported 1,203 shares. Regent Investment Mngmt Limited Liability reported 8,685 shares or 0.6% of all its holdings. Leavell Inc reported 6,585 shares stake. Hall Laurie J Trustee reported 0.34% of its portfolio in Thermo Fisher Scientific Inc. (NYSE:TMO). Etrade Mngmt Ltd Llc reported 0.09% of its portfolio in Thermo Fisher Scientific Inc. (NYSE:TMO). Moreover, Investec Asset Management North America Inc has 1.98% invested in Thermo Fisher Scientific Inc. (NYSE:TMO) for 133,164 shares. Fjarde Ap owns 112,871 shares or 0.35% of their US portfolio. Bokf Na owns 0.2% invested in Thermo Fisher Scientific Inc. (NYSE:TMO) for 34,996 shares. Moreover, Comerica Bank has 0.22% invested in Thermo Fisher Scientific Inc. (NYSE:TMO). Pennsylvania Tru reported 0.39% in Thermo Fisher Scientific Inc. (NYSE:TMO).

More news for Thermo Fisher Scientific Inc. (NYSE:TMO) were recently published by: Fool.com, which released: “3 Dividend Stocks Perfect for Retirees” on September 05, 2018. Seekingalpha.com‘s article titled: “Thermo Fisher to acquire advanced bioprocessing business from BD” and published on September 07, 2018 is yet another important article.

Analysts await Thermo Fisher Scientific Inc. (NYSE:TMO) to report earnings on October, 24. They expect $2.55 EPS, up 10.39% or $0.24 from last year’s $2.31 per share. TMO’s profit will be $1.03 billion for 23.71 P/E if the $2.55 EPS becomes a reality. After $2.75 actual EPS reported by Thermo Fisher Scientific Inc. for the previous quarter, Wall Street now forecasts -7.27% negative EPS growth.

Among 19 analysts covering Thermo Fisher Scientific (NYSE:TMO), 18 have Buy rating, 0 Sell and 1 Hold. Therefore 95% are positive. Thermo Fisher Scientific had 65 analyst reports since July 24, 2015 according to SRatingsIntel. The stock of Thermo Fisher Scientific Inc. (NYSE:TMO) earned “Buy” rating by Argus Research on Tuesday, October 6. As per Thursday, February 1, the company rating was maintained by Morgan Stanley. The firm has “Buy” rating by Robert W. Baird given on Wednesday, January 31. The rating was initiated by Goldman Sachs on Tuesday, September 26 with “Buy”. The firm earned “Outperform” rating on Thursday, November 10 by Leerink Swann. Stifel Nicolaus maintained Thermo Fisher Scientific Inc. (NYSE:TMO) rating on Monday, January 11. Stifel Nicolaus has “Buy” rating and $158 target. The firm has “Overweight” rating by JP Morgan given on Thursday, September 22. Jefferies downgraded the stock to “Hold” rating in Friday, April 29 report. The rating was maintained by Leerink Swann with “Buy” on Friday, April 28. The stock of Thermo Fisher Scientific Inc. (NYSE:TMO) has “Buy” rating given on Thursday, February 1 by Bank of America.

Oracle Corporation (NYSE:ORCL) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts